Search

Herbert Goldstein

Examiner (ID: 18423)

Most Active Art Unit
2608
Art Unit(s)
2607, 2403, 2616, 2613, 2214, 2605, 2611, 2608
Total Applications
1485
Issued Applications
1358
Pending Applications
2
Abandoned Applications
125

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18449582 [patent_doc_number] => 20230190858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => Treatment for Diseases Caused By RNA Viruses [patent_app_type] => utility [patent_app_number] => 18/169473 [patent_app_country] => US [patent_app_date] => 2023-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169473 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/169473
Treatment for diseases caused by RNA virus SARS-CoV-2 Feb 14, 2023 Issued
Array ( [id] => 18597627 [patent_doc_number] => 20230272424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR [patent_app_type] => utility [patent_app_number] => 18/165138 [patent_app_country] => US [patent_app_date] => 2023-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165138 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/165138
METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR Feb 5, 2023 Abandoned
Array ( [id] => 20240991 [patent_doc_number] => 12421299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-23 [patent_title] => Expression of FC-containing proteins [patent_app_type] => utility [patent_app_number] => 18/156215 [patent_app_country] => US [patent_app_date] => 2023-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 20343 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156215 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/156215
Expression of FC-containing proteins Jan 17, 2023 Issued
Array ( [id] => 18628516 [patent_doc_number] => 20230287381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/069651 [patent_app_country] => US [patent_app_date] => 2022-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 151084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069651 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/069651
PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF Dec 20, 2022 Pending
Array ( [id] => 18485197 [patent_doc_number] => 20230212524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => Methods and Compositions for Rapid Generation of Single and Multiplexed Reporters in Cells [patent_app_type] => utility [patent_app_number] => 18/080093 [patent_app_country] => US [patent_app_date] => 2022-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080093 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/080093
Methods and compositions for rapid generation of single and multiplexed reporters in cells Dec 12, 2022 Issued
Array ( [id] => 18537821 [patent_doc_number] => 20230242923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => GENERATION OF ACYL AMINO ACIDS [patent_app_type] => utility [patent_app_number] => 18/063629 [patent_app_country] => US [patent_app_date] => 2022-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063629 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063629
GENERATION OF ACYL AMINO ACIDS Dec 7, 2022 Pending
Array ( [id] => 18726264 [patent_doc_number] => 20230340532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR [patent_app_type] => utility [patent_app_number] => 18/061000 [patent_app_country] => US [patent_app_date] => 2022-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061000 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/061000
METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR Dec 1, 2022 Abandoned
Array ( [id] => 18468839 [patent_doc_number] => 20230203121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => Incretin Analogs and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/057398 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057398 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057398
Incretin analogs and uses thereof Nov 20, 2022 Issued
Array ( [id] => 18581603 [patent_doc_number] => 20230263855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => PEPTIDE-POLYNUCLEOTIDE-HYALURONIC ACID NANOPARTICLES AND METHODS FOR POLYNUCLEOTIDE TRANSFECTION [patent_app_type] => utility [patent_app_number] => 18/056823 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056823 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056823
PEPTIDE-POLYNUCLEOTIDE-HYALURONIC ACID NANOPARTICLES AND METHODS FOR POLYNUCLEOTIDE TRANSFECTION Nov 17, 2022 Pending
Array ( [id] => 18321113 [patent_doc_number] => 20230119241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => METHOD FOR SOLUBLE EXPRESSION AND PURIFICATION OF HYDROPHOBIN [patent_app_type] => utility [patent_app_number] => 18/056708 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056708 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056708
Method for soluble expression and purification of hydrophobin Nov 16, 2022 Issued
Array ( [id] => 18628579 [patent_doc_number] => 20230287452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR [patent_app_type] => utility [patent_app_number] => 18/054786 [patent_app_country] => US [patent_app_date] => 2022-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054786 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/054786
METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR Nov 10, 2022 Abandoned
Array ( [id] => 18452017 [patent_doc_number] => 20230193296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AND TRANSLATION EFFICIENCY [patent_app_type] => utility [patent_app_number] => 18/049593 [patent_app_country] => US [patent_app_date] => 2022-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049593 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/049593
Modification of RNA, producing an increased transcript stability and translation efficiency Oct 24, 2022 Issued
Array ( [id] => 18347374 [patent_doc_number] => 20230135484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/047953 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047953 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047953
METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION Oct 18, 2022 Abandoned
Array ( [id] => 18406075 [patent_doc_number] => 20230167426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => ANTI-CRISPR COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/959019 [patent_app_country] => US [patent_app_date] => 2022-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959019 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/959019
ANTI-CRISPR COMPOUNDS AND METHODS OF USE Oct 2, 2022 Pending
Array ( [id] => 18597609 [patent_doc_number] => 20230272406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => 3'-UTR SEQUENCES FOR STABILIZATION OF RNA [patent_app_type] => utility [patent_app_number] => 17/936377 [patent_app_country] => US [patent_app_date] => 2022-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936377 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/936377
3'-UTR sequences for stabilization of RNA Sep 27, 2022 Issued
Array ( [id] => 18420120 [patent_doc_number] => 20230174581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => PROCESSES AND AGENTS FOR GLAUCOMA [patent_app_type] => utility [patent_app_number] => 17/934661 [patent_app_country] => US [patent_app_date] => 2022-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28165 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/934661
PROCESSES AND AGENTS FOR GLAUCOMA Sep 22, 2022 Abandoned
Array ( [id] => 18193230 [patent_doc_number] => 20230046749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => METHOD FOR ISOLATING SPECIFIC GENOMIC REGIONS WITH USE OF MOLECULE CAPABLE OF SPECIFICALLY BINDING TO ENDOGENOUS DNA SEQUENCE [patent_app_type] => utility [patent_app_number] => 17/823685 [patent_app_country] => US [patent_app_date] => 2022-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9927 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823685 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/823685
METHOD FOR ISOLATING SPECIFIC GENOMIC REGIONS WITH USE OF MOLECULE CAPABLE OF SPECIFICALLY BINDING TO ENDOGENOUS DNA SEQUENCE Aug 30, 2022 Pending
Array ( [id] => 19909284 [patent_doc_number] => 12285471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-29 [patent_title] => Methods for treating pulmonary disease using inter-alpha inhibitor proteins [patent_app_type] => utility [patent_app_number] => 17/821713 [patent_app_country] => US [patent_app_date] => 2022-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9575 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821713 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/821713
Methods for treating pulmonary disease using inter-alpha inhibitor proteins Aug 22, 2022 Issued
Array ( [id] => 18018170 [patent_doc_number] => 20220369669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHOD FOR PRODUCING HYDROLYSED KERATINACEOUS MATERIAL [patent_app_type] => utility [patent_app_number] => 17/879291 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879291 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/879291
Method for producing hydrolysed keratinaceous material Aug 1, 2022 Issued
Array ( [id] => 18207658 [patent_doc_number] => 20230053915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => DIRECTED EDITING OF CELLULAR RNA VIA NUCLEAR DELIVERY OF CRISPR/CAS9 [patent_app_type] => utility [patent_app_number] => 17/811626 [patent_app_country] => US [patent_app_date] => 2022-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811626 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/811626
Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9 Jul 10, 2022 Issued
Menu